Evidence map›Paper›PMID 36132073›Full record

ArticleBioMed research international2022

L-Lysine Ameliorates Diabetic Nephropathy in Rats with Streptozotocin-Induced Diabetes Mellitus.

Faezeh Jozi, Nejat Kheiripour, Maryam Akhavan Taheri, Abolfazl Ardjmand, Gholamreza Ghavipanjeh, Zahra Nasehi, Mohammad Esmaeil Shahaboddin

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05903625 (Effect of Lysine and Phosphorous in Double Fortified Bread on Glycemic Index), which is not on this map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05903625 nacompletednot on this mapstarted 2023, after this paper: background citation

Effect of Lysine and Phosphorous in Double Fortified Bread on Glycemic Index (GI) of White Bread and Postprandial Glycemia

TypeinterventionalSponsorUniversity of Veterinary and Animal Sciences, Lahore - PakistanRan2023 to 2024Enrolled16ConditionsHyperglycemia, Glucose Metabolism Disorders, Metabolic Disease, Glycemic IndexArmsControl Group - Standard White Bread, Lysine Group - Lysine-Fortified Bread, Phosphorus Group - Phosphorus-Fortified Bread, Lysine and Phosphorus Group - Double Fortified Bread
3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 25 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Amino acid metabolism in kidney health and disease.Nature reviews. Nephrology · 2024
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Faezeh JoziDepartment of Clinical Biochemistry, Faculty of Medicine, Kashan University of Medical Sciences, Kashan, Iran.
Nejat KheiripourInstitute for Basic Sciences, Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences, Kashan, Iran.ORCID https://orcid.org/0000-0003-0684-7125
Maryam Akhavan TaheriInstitute for Basic Sciences, Anatomical Sciences Research Center, Kashan University of Medical Sciences, Kashan, Iran.ORCID https://orcid.org/0000-0002-6562-133X
Abolfazl ArdjmandInstitute for Basic Sciences, Physiology Research Center, Kashan University of Medical Sciences, Kashan, Iran.ORCID https://orcid.org/0000-0002-9637-1759
Gholamreza GhavipanjehInstitute for Basic Sciences, Physiology Research Center, Kashan University of Medical Sciences, Kashan, Iran.ORCID https://orcid.org/0000-0002-5733-4859
Zahra NasehiDepartment of Clinical Biochemistry, Faculty of Medicine, Kashan University of Medical Sciences, Kashan, Iran.ORCID https://orcid.org/0000-0002-7647-6756
Mohammad Esmaeil ShahaboddinDepartment of Clinical Biochemistry, Faculty of Medicine, Kashan University of Medical Sciences, Kashan, Iran.ORCID https://orcid.org/0000-0002-3100-3576
Kashan University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Diabetic nephropathy is one of the leading causes of end-stage renal disease worldwide. Uncontrolled hyperglycemia and subsequent production of glycation end-products activate the paths which lead to diabetic nephropathy. The aim of this study was to assess the effects of L-lysine on antioxidant capacity, biochemical factors, kidney function, HSP70 level, and the expression of the Methods: Thirty-two male Wistar rats were randomly allocated to four eight-rat groups, namely, a healthy group, a diabetic group treated with vehicle (DM + vehicle), a diabetic group treated with L-lysine (DM + Lys), and a healthy group treated with L-lysine (healthy + Lys). Rats in the DM + Lys and the healthy + Lys groups were treated with L-lysine 0.15%. The levels of fasting blood glucose, insulin, HbA Conclusion: Treatment with L-lysine seems to slow down the progression of diabetic nephropathy.

Indexed as

Diabetes Mellitus, ExperimentalDiabetic NephropathiesAnimalsAntioxidantsBlood GlucoseCreatinineGlycation End Products, AdvancedInsulinKidneyLipidsLysineMaleOxidative StressRatsRats, WistarStreptozocinAntioxidantsBlood GlucoseCreatinineGlycation End Products, AdvancedInsulinLipidsLysineStreptozocinTransforming Growth Factor betaVascular Endothelial Growth Factor A

Identifiers

PMID36132073
PMCPMC9484891
OpenAlexW4295677356

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.